Details for New Drug Application (NDA): 050504
✉ Email this page to a colleague
NDA 050504 describes MANDOL, which is a drug marketed by Lilly and is included in two NDAs. Additional details are available on the MANDOL profile page.
The generic ingredient in MANDOL is cefamandole nafate. There are five drug master file entries for this compound. Additional details are available on the cefamandole nafate profile page.
The generic ingredient in MANDOL is cefamandole nafate. There are five drug master file entries for this compound. Additional details are available on the cefamandole nafate profile page.
Summary for 050504
| Tradename: | MANDOL |
| Applicant: | Lilly |
| Ingredient: | cefamandole nafate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050504
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
